Changes in Cardiovascular Health Status and the Risk of New-Onset Hypertension in Kailuan Cohort Study

被引:5
|
作者
Gao, Fei [1 ]
Liu, Xiaoxue [2 ]
Wang, Xizhu [2 ]
Chen, Shouhua [3 ]
Shi, Jihong [4 ]
Zhang, Ying [5 ]
Wu, Shouling [4 ]
Cai, Jun [6 ,7 ]
机构
[1] Univ Hong Kong, LKS Fac Med, Dept Opthalmol, Hong Kong, Hong Kong, Peoples R China
[2] North China Univ Sci & Technol, Tangshan Peoples Hosp, Dept Cardiol, Tangshan, Peoples R China
[3] North China Univ Sci & Technol, Kailuan Hosp, Dept Hlth Care Ctr, Tangshan, Peoples R China
[4] North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China
[5] North China Univ Sci & Technol, Hosp, Dept Ultrasonog, Tangshan, Peoples R China
[6] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Hyertens, Beijing, Peoples R China
[7] Peking Union Med Coll, Beijing, Peoples R China
来源
PLOS ONE | 2016年 / 11卷 / 07期
关键词
C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; URIC-ACID LEVELS; ASSOCIATION; PREVALENCE; INFLAMMATION; POPULATION; MORTALITY; METRICS; IMPACT;
D O I
10.1371/journal.pone.0158869
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
American Heart Association cardiovascular health metrics are intimately related to cardiovascular diseases. Acting as a key independent risk factor for high morbidity and mortality of cardiovascular diseases, hypertension and its relationship between health status get urgent attention. While the influence of individual health status changes and the future risk of new-onset hypertension is rarely understood, the present study applied this construct to assess the changes of cardiovascular health status and the morbidity of hypertension in Kailuan cohort study in north China. The Cardiovascular Health Score (CHS) was evaluated by the follow-ups of 2006-2007, 2008-2009, 2010-2011 and 2012-2013. The study population (n = 19381) was divided into 5 groups based on the changes in their CHS score between the first two follow-ups (Delta CHS) of 2006-2007 and 2008-2009 (<=-2, -1, 0, 1, >= 2). The morbidity of hypertension was collected during 2010-2011 and 2012-2013 follow-ups. Data analysis showed that during a median follow-up of 3.79 +/- 0.96 years, morbidity of hypertension had a graded relationship with Delta CHS. As Delta CHS scored from low to high, the standardized morbidity of hypertension for all participants were 81.40, 75.47, 68.37, 71.43 and 83.13 per 1000 person-year, respectively. An increased Delta CHS score of 1 was associated with a 10% decrease in the future risk of new-onset hypertension(HR: 0.90, 95% CI: 0.88-0.92). In conclusion, there was a strong inverse relationship between the incidence of new-onset hypertension and elevation of cardiovascular health metrics. Population-wide prevention, especially the promotion of lifestyle improvements, is critical to reducing the morbidity of new-onset hypertension.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] The positive association between the atherogenic index of plasma and the risk of new-onset hypertension: a nationwide cohort study in China
    Yuan, Yue
    Shi, Jing
    Sun, Wei
    Kong, Xiangqing
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2024, 46 (01)
  • [32] Performance of Cardiovascular Risk Prediction Models in Korean Patients With New-Onset Rheumatoid Arthritis: National Cohort Study
    Kim, Jae Hyun
    Lee, Gaeun
    Hwang, Jinseub
    Kim, Ji-Won
    Kwon, Jin-Won
    Song, Yun-Kyoung
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (22):
  • [33] REPLY: Different Cardiovascular Outcomes in New-Onset Hypertension in China
    Wang, Chi
    Yuan, Yu
    Wu, Shouling
    Xue, Hao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (15) : 1813 - 1814
  • [34] Cardiovascular drugs that increase the risk of new-onset diabetes
    Ong, Kwok Leung
    Barter, Philip J.
    Waters, David D.
    AMERICAN HEART JOURNAL, 2014, 167 (04) : 421 - 428
  • [35] Prevalence and Risk Factors for New-Onset Hypertension in Labor
    Ankumah, Nana-Ama E.
    Alrais, Mesk A.
    Amro, Farah H.
    Wiley, Rachel L.
    Sibai, Baha M.
    AMERICAN JOURNAL OF PERINATOLOGY, 2020, 37 (05) : 543 - 547
  • [37] The comparative risk of new-onset diabetes after prescription of drugs for cardiovascular risk prevention in primary care: a national cohort study
    Currie, Olivia
    Mangin, Dee
    Williman, Jonathan
    McKinnon-Gee, Bianca
    Bridgford, Paul
    BMJ OPEN, 2013, 3 (11):
  • [38] Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension
    Triches, Cristina Bergmann
    Mayer, Saurus
    Redublo Quinto, Beata Marie
    Batista, Marcelo Costa
    Zanella, Maria Teresa
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (05): : 935 - 941
  • [39] Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
    Lindholm, LH
    Ibsen, H
    Borch-Johnsen, K
    Olsen, MH
    Wachtell, K
    Dahlöf, B
    Devereux, RB
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Kristianson, K
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Aurup, P
    Edelman, JM
    Snapinn, S
    JOURNAL OF HYPERTENSION, 2002, 20 (09) : 1879 - 1886
  • [40] The effects of hypertension and diabetes on new-onset chronic kidney disease: A prospective cohort study
    Wang, Miao
    Li, Junjuan
    Li, Yao
    Yao, Siyu
    Zhao, Maoxiang
    Wang, Chi
    Wu, Shouling
    Xue, Hao
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (01): : 39 - 46